TREM2-expressing macrophages in liver diseases
Authors:
- 13 May 2025
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 37 (1) , 55-67
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK133283)
- National Institutes of Health
- Cancer Prevention and Research Institute of Texas (RR180014)
- Cancer Prevention and Research Institute of Texas (RP200197)
- Cancer Prevention and Research Institute of Texas (RP230261)
- Cancer Prevention and Research Institute of Texas (RP240183)
- National Institute of General Medical Sciences (R35GM142654)
This publication has 99 references indexed in Scilit:
- Novel insights into the role of TREM2 in cerebrovascular diseasesBrain Research, 2024
- Distinct roles of TREM2 in central nervous system cancers and peripheral cancersCancer Cell, 2024
- A multisociety Delphi consensus statement on new fatty liver disease nomenclatureAnnals of Hepatology, 2023
- Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffnessHepatology, 2022
- Immune phenotypic linkage between colorectal cancer and liver metastasisCancer Cell, 2022
- DNAX Activating Protein of 12 kDa/Triggering Receptor Expressed on Myeloid Cells 2 Expression by Mouse and Human Liver Dendritic Cells: Functional Implications and Regulation of Liver Ischemia–Reperfusion InjuryHepatology, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease ModelCell, 2015
- Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #Hepatology, 2009
- CCR2 promotes hepatic fibrosis in mice #Hepatology, 2009